ISSN 1016-5169 | E-ISSN 1308-4488
Gender Differences in Mechanical Circulatory Support, Heart Transplantation, and Survival Among Patients with Advanced Heart Failure [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2026; 54(1): 13-23 | DOI: 10.5543/tkda.2025.88663

Gender Differences in Mechanical Circulatory Support, Heart Transplantation, and Survival Among Patients with Advanced Heart Failure

Seda Tanyeri Üzel1, Barkın Kültürsay2, Murat Karaçam3, Deniz Mutlu4, Azmican Kaya1, Süleyman Çağan Efe1, Gülümser Sevgin Halil1, Özgür Yaşar Akbal1, Cem Doğan1, Kaan Kirali5, Rezzan Deniz Acar1
1Department of Cardiology, Kartal Kosuyolu Training and Research Hospital, Istanbul, Türkiye
2Department of Cardiology, Tunceli State Hospital, Tunceli, Türkiye
3Department of Cardiology, Bitlis State Hospital, Bitlis, Türkiye
4Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
5Department of Cardiovascular Surgery, Kartal Kosuyolu Training and Research Hospital, İstanbul, Türkiye

Objective: Despite growing awareness of sex-based disparities in heart failure (HF), their impact on clinical outcomes in advanced stages remains poorly understood, largely due to confounding in observational data. This study aimed to assess the independent effect of biological sex on clinical outcomes in advanced HF.

Method: In this retrospective cohort study, 522 patients with advanced HF (85.2% male) evaluated between 2021 and 2024 underwent comprehensive assessments, including echocardiography, cardiopulmonary exercise testing, and cardiac catheterization. Covariate balance was achieved using inverse probability weighting (IPW) based on propensity scores. Primary outcomes included left ventricular assist device (LVAD) implantation, heart transplantation, all-cause mortality, and a composite of these events. Cox proportional hazards models were applied, with a median follow-up of 864 days.

Results: At baseline, male patients were older (54.0 vs. 49.5 years; P = 0.025), had higher rates of ischemic etiology (49.9% vs. 22.7%; P < 0.001), larger cardiac dimensions, and superior exercise capacity. Following IPW adjustment, female sex was associated with a significantly lower risk of LVAD implantation (hazard ratio [HR]: 0.13; 95% confidence interval [CI]: 0.04–0.40; P < 0.001). In contrast, no significant sex-related difference was found in all-cause mortality (HR: 0.75; 95% CI: 0.36–1.58; P = 0.43). The composite outcome showed a non-significant trend toward better outcomes in women (HR: 0.53; 95% CI: 0.26–1.06; P = 0.076). These findings should be interpreted in the context of the relatively small female cohort (14.8%).

Conclusion: In patients with advanced HF, female sex was associated with a lower likelihood of LVAD implantation without an effect on overall mortality. These findings suggest that advanced HF may follow distinct pathophysiological trajectories in women and men, underscoring the importance of sex-informed clinical decision-making frameworks to optimize management and outcomes.

Keywords: Advanced heart failure, sex differences, left ventricular assist device, mechanical circulatory support, inverse probability weighting, propensity score


Corresponding Author: Seda Tanyeri Üzel
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2026 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.